Form 4: Alignment Healthcare CDO to Receive 23,441 RSUs

Sentiment:

Insider Transaction Report


Alignment Healthcare's Chief Digital Officer, Adnan R. Mansour, is set to receive 23,441 restricted stock units, vesting over three years starting in 2027.

Summary

  • Adnan R. Mansour, Chief Digital Officer of Alignment Healthcare, Inc. (ALHC), will acquire 23,441 shares of Common Stock in the form of restricted stock units (RSUs).
  • The transaction date for this acquisition is February 23, 2026.
  • These restricted stock units will vest in approximately equal installments on February 4, 2027, February 4, 2028, and February 4, 2029.
  • Vesting is contingent upon Mr. Mansour's continued service to the company on each applicable vesting date.
  • The acquisition price for these RSUs is $0 per unit, typical for a grant of restricted stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices aimed at aligning management incentives with long-term shareholder value and ensuring executive retention.

Positives

  • The grant of restricted stock units aligns the Chief Digital Officer's long-term interests with those of shareholders, incentivizing sustained company performance.
  • This compensation structure serves as a retention mechanism for a key executive, ensuring continuity in leadership and strategic execution.

Future Outlook

The vesting schedule for the restricted stock units extends through February 2029, indicating an expectation of continued service from the Chief Digital Officer and a long-term incentive structure.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of executive compensation in the healthcare technology sector, aligning executive incentives with long-term company performance and shareholder value. This grant to a Chief Digital Officer underscores the importance of digital strategy and innovation within the industry.

Comparison to Industry Standards

  • RSU grants are a widely adopted compensation mechanism across the technology and healthcare sectors, aligning executive incentives with long-term shareholder value creation.
  • While specific grant sizes vary by company size, executive role, and performance metrics, the structure of multi-year vesting, contingent on continued service, is standard practice for executive retention and motivation.

Stakeholder Impact

  • Shareholders: Positive impact through enhanced alignment of executive interests with long-term company performance.
  • Employees (specifically Adnan R. Mansour): Positive impact through significant equity compensation, incentivizing continued service and performance.

Next Steps

  • The restricted stock units will vest in approximately equal installments on February 4, 2027, February 4, 2028, and February 4, 2029, subject to continued service.

Key Dates

DateDescription
02/23/2026Transaction date for the acquisition of 23,441 restricted stock units by Adnan R. Mansour.
02/04/2027First vesting date for a portion of the restricted stock units.
02/04/2028Second vesting date for a portion of the restricted stock units.
02/04/2029Third and final vesting date for a portion of the restricted stock units.

Recommendation

hold

This Form 4 reports a standard restricted stock unit grant to a key executive, which is a routine compensation event and does not provide new fundamental information to alter an investment thesis. It primarily serves to align executive incentives with long-term company performance.

Keywords

Alignment Healthcare, ALHC, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Adnan R. Mansour, Chief Digital Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.